Chinaâs YolTech Therapeutics, a biotechnology startup, has started its clinical trial of an investigational therapy for treating transfusion-dependent beta-thalassemia (TDT), a severe genetic
US adults with attention deficit hyperactivity disorder (ADHD) rose from 10.6% to 15.2% between 2020 and 2023, and Covid-19 pandemic may be a
Daiichi Sankyo, the second-largest pharmaceutical company in Japan in terms of revenue, has set up a laboratory in the US for robotic development,
HQ Team January 21, 2024: The popular diabetes drugs, glucagon-like peptide-1 (GLP-1) receptor agonists such as Ozempic, have gained immense popularity for their
The US Food and Drug Administration has approved Johnson & Johnsonâs nasal spray in adults who have had an inadequate response to at
The US, the worldâs second-largest greenhouse gas emitter in the world, will withdraw from a global pact to limit global warming.
The US, the World Health Organizationâs top donor, has decided to withdraw from the global health body, accusing it of âmishandlingâ the Covid-19
HQ Team January 20, 2024:People with fat stored within their muscles, known as intermuscular fat, face a significantly higher risk of serious cardiovascular
